MUMBAI, India, June 24, 2026 /PRNewswire/ -- In a major breakthrough for clinical artificial intelligence, the LaennecAI Clinical Research Team announced today that Zorgm Pro, an educational reference ...

Trace Neuroscience, Inc., a biopharmaceutical company expanding the promise of genomic medicine for people living with neurodegenerative diseases, today announced the initiation of its global clinical ...

War is a brutal driver of medical innovation. Russia’s full-scale invasion of Ukraine has forced clinicians and commanders alike to confront a hard truth: Survival depends not only on tactics and ...

Spoiler alert! We're discussing major plot details about Pixar’s animated movie "Toy Story 5” (in theaters now). Stop reading if you haven’t seen it yet and don’t want to know what happens. Before you ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Ruth Linehan explains how migrating ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Artificial intelligence is transforming every stage of clinical trials. Artificial ...

You hear it all the time. Hell, you might have even said it yourself (I know I have): “Hollywood’s out of ideas!” That sentiment can often seem true in a market where studio executives favor sequels ...

Procter & Gamble remains a high-quality defensive business, but the stock still does not look cheap enough for a Buy. P&G delivered a clear revenue beat, with core EPS of $1.59 versus $1.56 expected ...

Phase II trial evaluating nivolumab in patients with recurrent IDH-mutant gliomas with and without hypermutation phenotype. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...